Approximately 15% of peripheral T‐cell lymphoma (PTCL) patients harbor Vav1 gene rearrangements, predominantly the Vav1–THAP4 fusion variant. The gene discussed is VAV1; the disease is mature T-cell and NK-cell non-Hodgkin lymphoma.